BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Lovastatin
,
rs7903146
,
ZBTB7A
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD22
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
B lymphocyte (naive) of spleen
B lymphocyte (IgM memory) of spleen
Atrioventricular node
Spleen
Tonsil
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Methicillin resistant Staphylococcus aureus infection
Disease caused by rickettsiae
Irritable bowel syndrome
Disease caused by parasite
Brucellosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Methylnitronitrosoguanidine
2-methylthio-ATP
Immunotoxins
R 406 cpd
ovalbumin-alum
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
GAB2
TERF2
RHO
EPHA2
USP18
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Impli…
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics.
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Targeting CD22 on memory B cells to induce tolerance to peanut allergens.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymph…
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+C…
CD22 Redirected Autologous T Cells for ALL
Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ